Multiple mechanisms of aminoglycoside ototoxicity are distinguished by subcellular localization of action

Mechanosensory hair cells of the inner ears and lateral line of vertebrates display heightened vulnerability to environmental insult, with damage resulting in hearing and balance disorders. An important example is hair cell loss due to exposure to toxic agents including therapeutic drugs such as the aminoglycoside antibiotics neomycin and gentamicin and antineoplastic agents. We describe two distinct cellular pathways for aminoglycoside-induced hair cell death in zebrafish lateral line hair cells. Neomycin exposure results in death from acute exposure with most cells dying within 1 h of exposure. By contrast, exposure to gentamicin results primarily in delayed hair cell death, taking up to 24 h for maximal effect. Washout experiments demonstrate that delayed death does not require continuous exposure, demonstrating two mechanisms where downstream responses differ in their timing. Acute damage is associated with mitochondrial calcium fluxes and can be alleviated by the mitochondrially-targeted antioxidant mitoTEMPO, while delayed death is independent of these factors. Conversely delayed death is associated with lysosomal accumulation and is reduced by altering endolysosomal function, while acute death is not sensitive to lysosomal manipulations. These experiments reveal the complexity of responses of hair cells to closely related compounds, suggesting that intervention focusing on early events rather than specific death pathways may be a successful therapeutic strategy.

Introduction

The inner ear is essential for normal vocal communication, for localizing acoustic information and for balance. The sensitivity of the ear to disease and injury is evident by the large number of mutations that affect its development and maintenance (1, 2), and by the well-documented susceptibility of hair cells to damage from important therapeutic agents such as aminoglycoside (AG) antibiotics and antineoplastic agents including cisplatin (3–6). AGs are standard-of-care treatment for life-threatening diseases of the lung, including multidrug-resistant tuberculosis (7, 8), non-tuberculous mycobacterium (9), and Pseudomonas infections associated with cystic fibrosis (10–14), with associated hearing loss ranging from 11 to 67% of patients reported in these studies. In some cases, damage to vestibular organs is even more prevalent than hearing loss (14). Aminoglycoside use has been estimated to contribute to nearly 20 million cases of hearing loss globally (15). Understanding how AG exposure results in hair cell death may provide potential therapeutic avenues to make these important drugs safer.

The zebrafish lateral line system has emerged as a useful model for identifying hearing-related genes and their functions, and for understanding cellular pathways underlying some forms of hair cell death [reviewed in Stawicki et al., Coffin and Ramcharitar, Nicolson, Kindt and Sheets, and Pickett and Raible (16–20)]. Mechanosensory hair cells are located on the surface of the body in clusters, called neuromasts (NMs), making them amenable to visualization and manipulation. Like hair cells of the inner ear, lateral line hair cells demonstrate hypersusceptiblity to damage by exposure to toxic chemicals, including AGs and cisplatin (21–23). The zebrafish lateral line system has proven useful in screening for ototoxic drugs (24–28) and screening for potentially protective therapeutics (29–32).

In zebrafish, intercompartmental calcium (Ca²⁺) flows play a central role in lateral line hair cell toxicity after acute exposure to the AG, neomycin. Treatment with neomycin results in endoplasmic reticulum flow of Ca²⁺ via IP₃ channels to mitochondria, with subsequent loss of mitochondrial membrane potential (33, 34). Ultrastructural analyses of zebrafish hair cells after AG exposure revealed rapid loss of mitochondrial integrity that results in hair cell death (35). Increases in mitochondrial Ca²⁺ are accompanied by increases in reactive oxygen species (ROS), and modulating mitochondrial ROS production confers some protection against neomycin damage (36). Together, these studies suggested a model where neomycin disruption of ER-mitochondrial Ca²⁺ flows resulted in mitochondrial collapse, and cell death. However, it is not clear whether this model is generalizable to other ototoxins, including other AG antibiotics.

Previous studies have demonstrated differences in temporal response of lateral line hair cells to different AGs (37, 38), suggesting that there may be multiple pathways by which zebrafish hair cells die from AG exposure. However, they did not distinguish between time of toxin exposure compared to time taken for cell death to progress. By varying both AG concentration and time of exposure, we now provide evidence for an acute mechanism that happens within minutes of AG exposure and a delayed mechanism that occurs for hours after AG exposure. The two patterns display distinct intracellular Ca²⁺ dynamics and differential accumulation of AGs in lysosomes. We further demonstrate that treatment with mitochondrial targeted antioxidants protects against acute death but not delayed death, while altering lysosomal distribution protects against delayed but not acute damage. Together, these studies reveal multiple vulnerabilities of hair cells to AG exposure and suggest that development of therapeutic approaches to preserve hearing and balance need to consider common and distinct pathways underlying damage.

Methods

Animals

Experiments were conducted on 5–8 dpf (days postfertilization) larval zebrafish. Larvae were raised in embryo medium (EM; 14.97 mM NaCl, 500 μM KCL, 42 μM Na₂HPO₄, 150 μM KH₂PO₄, 1 mM CaCl2 dihydrate, 1 mM MgSO₄, 0.714 mM NaHCO₃, pH 7.2) at 28.5°C. All wildtype animals were of the AB strain. Zebrafish experiments and husbandry followed standard protocols in accordance with University of Washington Institutional Animal Care and Use Committee guidelines.

We used four different transgenic lines in this study. The Tg(myosin6b:RGECO1)^vo10Tg line, expressing the red Ca²⁺ indicator RGECO in the cytoplasmic compartment, has been previously described (39) and was provided as gift from Katie Kindt (National Institute of Deafness and Other Communication Disorders, Bethesda, MD, USA). The Tg(myosin6b:MITO-GCaMP3)^w119Tg line, expressing the green Ca²⁺ indicator GCaMP in the mitochondrial compartment, was described previously (34). The line Tg(pou4f3:GAP-GFP)^s273tTg expresses membrane-tagged Green Fluorescence Protein (GFP) in hair cells (40). The line Tg(myosin6b:EGFP-rab7a)^w272Tg was generated using the Tol2 transposon (41) and the hair cell-specific myo6b promoter (42) to direct expression of eGFP fused 5′ to the zebrafish rab7ab gene (43).

AG treatment

To assess the relative toxicity of AGs, 5–8 dpf larvae were treated with neomycin (Sigma-Aldrich, N1142), gentamicin (Sigma-Aldrich, G1397) or G418 (Sigma-Aldrich, A1720). For acute treatment, larvae were exposed to AG in EM for 1 h, and then were rinsed 3x in EM, euthanized with 1.3% MESAB (MS-222; ethyl-m-aminobenzoate methanesulfonate; Sigma-Aldrich, A5040) and fixed (see below) for hair cell analysis. For delayed (1+23 h) treatment, larvae were treated for 1 h in AG, then rinsed 3x in EM followed by incubation in EM for 23 h, euthanized and fixed for hair cell analysis. For 24 h treatment, larvae were treated with AG for 24 h, and then were rinsed 3x in EM, euthanized and fixed for hair cell analysis.

To test whether subcellular localization influenced toxicity, larvae were first treated with drugs that alter lysosomal or mitochondria function. We used 250 μM GPN (glycyl-l-phenylalanine 2-naphthylamide; Cayman, 14634), or 100 nM Bafilomycin A1 (Sigma-Aldrich, B1793) to alter lysosomal function, or with 50 μM mitoTEMPO (Sigma-Aldrich, SML0737) to alter mitochondrial oxidation. Drugs were first added for 1 h (GPN and Bafilomycin) or 30 min (mitoTEMPO) before the addition of AG for 1 h.

To assess AG accumulation in hair cells we conjugated G418 or neomycin to the fluorophore Texas Red-X-succinimidyl ester (ThermoFisher, T6134) or G418 to BODIPY 650/665-X NHS Ester (Succinimidyl ester; ThermoFisher, D10001) following protocols for gentamicin labeling (44, 45) with previously described modifications (46). For lysosomal distribution experiments, groups of 3 5 dpf larvae were incubated in embryo media (EM) with 250 μM GPN for 1 h. Then, G418-Bodipy650 was added to final concentration of 50 μM for 1 h. Larvae were then mounted and imaged (described below). For experiments comparing AG distribution in hair cells, groups of 2 5 dpf larvae were imaged at a time. Larvae were exposed to 25 μM Neomycin-Texas Red or G418-Texas Red for 5 min in EM. Drug was washed out by transferring larvae to a 60 x 15 mm Petri dish (Falcon, 351007) containing EM+0.2% MESAB for 1 min, mounted and imaged (described below).

Hair cell analysis

Larvae were fixed with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS, pH 7.4) for 1 h at room temperature (RT) in a slow moving rocker. Larvae were then washed 3x with PBS for 15 min at RT and blocked in PBS supplemented with 0.1% Triton-X 100 and 5% normal goat serum (Sigma-Aldrich, 11H280) for 1–2 h at RT. Samples were incubated in mouse anti-parvalbumin antibody (1:400; EMD Millipore, MAB1572) in blocking solution (PBS supplemented with 0.1% Triton-X 100 and 1% normal goat serum) at 4°C overnight. Then samples were rinsed with PBS-T (PBS, 1% Triton-X 100) and subsequently incubated in goat anti-mouse antibody conjugated to Alexa 488 or 568 (1:500; ThermoFisher, A-11001, A11004) in blocking solution at 4°C overnight. Larvae were rinsed with PBS-T 3x for 15 min at RT, then with PBS 3x for 15 min at RT, and mounted between coverslips with Fluoromount G (SouthernBiotech, 0100-01). Hair cells were counted using a Zeiss Axioplan 2ie epifluorescence microscope with a Plan-NEOFLUAR 40x/0.75 NA objective (Zeiss). Counts were performed on four neuromasts (NMs) per fish [SO1, SO2, O1, and OC1; (47)] and summed to arrive at one value per fish. Hair cell counts were performed for 9–13 fish per treatment condition.

Calcium imaging

Calcium imaging was performed on live fish as previously described (34) using an inverted Marianas spinning disk system (Intelligent Imaging Innovations, 3i) with an Evolve 10 MHz EMCCD camera (Photometrics) and a Zeiss C-Apochromat 63x/1.2 NA water objective. Fish were stabilized using a slice anchor harp (Harvard Instruments) so that neuromasts on immobilized animals had access to the surrounding media. Imaging was performed at ambient temperature, typically 25°C. Baseline fluorescence readings were taken before AG exposure in 30 s intervals for 2.5 min. Aminoglycoside was added as a 4X concentrated stock to achieve the final indicated concentration. Fluorescence intensity readings were acquired at 30 s intervals for 60 min. Camera intensification was set to keep exposure times < 50 ms for GCaMP, 250 ms for cytoRGECO while keeping pixel intensity < 25% of saturation. Camera gain was set at 3X to minimize photobleaching. Z-sections were taken at 1 μm intervals through the depth of the neuromast, typically 24 μm. GCaMP fluorescence was acquired with 488 nm laser and 535/30 emission filter. RGECO was acquired with a 561 nm laser and a 617/73 emission filter.

For analyses, maximum intensity projections were generated and frames were auto-aligned using SlideBook software (Intelligent Imaging Innovations) to account for XY drift, typically < 50 pixels. ROIs outlining the cell of interest were drawn by hand, enabling us to correct for individual cell movement when necessary. Cells were categorized as living or dying based on their clearance from the neuromast. Fluorescence intensities were calculated relative to the mean baseline intensity of each individual hair cell before aminoglycoside exposure. Change in calcium was defined as two standard deviations over baseline. For each treatment condition, at least three replications were performed on different days and fluorescence intensities of no more than three cells per neuromast and two neuromasts per animal were used in analyses. Living and dying cells were chosen randomly for analysis at the end of each time lapse.

Confocal image acquisition

Live larvae were anesthetized in EM+0.2% MESAB, and then transferred to a glass-bottom chamber (Ibidi, m-Slide 2) and mounted using a small piece of 1 x 1 mm net, and two slice tissue harps (Warner Instruments, SHD-26GH/10 and SHD-27LH/10). Larvae were imaged using a Zeiss LSM 980 Airyscan inverted microscope, using a LD LCI Plan-Apochromat 40x/1.2NA Imm autocorr DIC objective (Zeiss). Correction collar was set to a relative position of 70% [Tg(myosin6b:EGFP)] or 75% [Tg(myosin6b:EGFP-Rab7a)]. 6x digital zoom was used. Z-stack span was defined for each neuromast, keeping an interval of 0.21 μm. Images were obtained using the Airyscan FAST SR-4Y scanning method, with optimal sampling confirmed by Zen Blue 3.7. The laser line was aligned to the Airyscan sensor array before imaging each larvae group.

Image processing

3D Airyscan processing of all images was performed on Zen Blue 3.7, with a strength value of 4.5 for all channels. For images of Tg(myosin6b:EGFP-Rab7a) larvae, background fluorescence was subtracted on the EGFP-Rab7a channel using the rolling ball macro in FIJI (48), with a pixel size of 10. For images of Tg(myosin6b:EGFP) larvae, a custom Python script (49), was used to align the z-stacks with the pystackreg Python port of StackReg (50). Using parameters of “rigid body” as method and “previous” as reference settings, alignment matrices were calculated using the cytoplasmic GFP signal, and then applied to all channels. Alignment matrices, and aligned images were then saved as OME.tiff files. A third of images were randomly selected and visually examined to make sure alignment was done correctly.

Image segmentation

We used 3D automated image segmentation to measure the accumulation of labeled AGs into vesicles. To segment the neuromast using the EGFP-Rab7a signal, we applied a strong gaussian filter (sigma value of 6), followed by triangle threshold (51) from scikit-image (52). This mask was processed to fill artificial holes and eliminate small artifacts generated during the segmentation. To create the background mask, we used the inverted neuromast mask. To segment neuromasts and hair cells using the myosin6b:EGFP transgene, we implemented a two-step semi-automated process, with a final user correction step. First, a background mask was created by thresholding using a multi-Otsu function from scikit-image (53), with a class value of 5. We then replaced pixel intensity in the background mask with an arbitrary value of 1.0e⁻⁷. To identify hair cells, we next created a mask by applying a Sauvola local thresholding (54), with a window size of 45 and a k-value of 0.2. This mask was processed to fill artificial holes and eliminate small artifacts generated during the segmentation. Individual hair cells were then identified using watershed segmentation. Seeds (one per cell) were added manually using a distance transform map as reference, using a Napari points layer (55). Watershed segmentation results were visualized in Napari, and errors in the cell masks were corrected by hand using the draw function.

Vesicles were segmented using the Allen Cell and Structure Segmenter (56). Files were loaded and visualized using Napari viewer and the range of slices in the stack that contain the neuromast image were selected. Intensity normalization function was applied to both channels. Vesicles were segmented using the 2D slice-by-slice dot wrapper and 2D filament wrapper functions from the Allen Cell Classic Segmenter package (56) with the following parameters: for EGFP-Rab7a vesicles (Figure 5), Dot segmenter parameters: scale_spot_1 = 4, cutoff_spot_1 = 0.5, scale_spot_2 = 2, cutoff_spot_2 = 0.08, and Filament segmenter parameter: scale_fil_1 = 2, cutoff_fil_1 = 1, scale_fil_2 = 1, cutoff_fil_2 = 0.9; for G418 vesicles (Figure 6), Dot segmenter parameters: scale_spot_1 = 4, cutoff_spot_1 = 0.04, scale_spot_2 = 1, cutoff_spot_2 = 0.05, and Filament segmenter parameter: scale_fil_1 = 3, cutoff_fil_1 = 0.2, scale_fil_2 = 2, cutoff_fil_2 = 0.09. The two segmenter results were fused together to create a single vesicle mask. This mask was then processed to fill artificial holes and eliminate small segmentation artifacts. To identify individual vesicles we used the label function from scikit-image (57), acknowledging that some vesicle masks might end up labeled together. Any segmented vesicles outside the neuromast mask were discarded for further analysis. A cytoplasmic mask was created by subtracting the vesicular mask from the whole neuromast mask. Properties for each segmented mask were calculated using regionprops_table function from scikit-image.

Statistical analyses

Mann-Whitney tests, T-tests, one way or two-way ANOVA with post-hoc testing was performed using GraphPad Prism. For graphical presentation, data were normalized to untreated controls such that 100% represents hair cell survival in control animals. Results were considered significant if p ≤ 0.05 with levels of statistical significance shown in figures as follows: ^*0.01–0.05, ^**0.001–0.01, ^***0.0001–0.001, ^**** < 0.0001.

Results

Distinct mechanisms of hair cell death are revealed by varying the exposure times to AGs

To illustrate differences in susceptibility to damage, we compare hair cell death after exposure to two different AGs, neomycin and gentamicin (Figure 1). After 1 h exposure (Figure 1A), there was substantial loss of hair cells with 200 μM neomycin treatment, whereas exposure to the same concentration of gentamicin had little effect at this time point. After 24 h (Figure 1B), there was substantial damage with both AGs. We considered two hypotheses to account for the difference in gentamicin exposure resulting in these different outcomes. One possibility was that continuous exposure to gentamicin over 24 h was required for damage similar to that seen with a comparable concentration of neomycin to occur. Alternatively, the cellular responses to damage after exposure to gentamicin might be delayed, requiring further incubation time but not additional exposure. To distinguish between these ideas, we treated hair cells with AGs for 1 h, followed by rinsing in fresh medium to remove all AG, and then incubating for an additional 23 h (designated 1+23 h treatment). We found that 1 h exposure to 200 μM gentamicin was sufficient to cause damage comparable to that seen with neomycin if animals were incubated an additional 23 h in fresh medium (Figure 1C). These results are consistent with the idea that 1 h gentamicin exposure results in cell death processes that are substantially delayed compared to those that result from 1 h neomycin treatment.

Figure 1

Figure 1. AGs differ in relative hair cell toxicity dependent on time of exposure and length of incubation. (A–C) Fish were treated with 200 μM neomycin (Neo) or gentamicin (Gent; red bar) for time indicated, or rinsed into fresh medium (blue bar). (A) Hair cells were exposed for 1 h acute treatment with AGs. Hair cells are effectively killed by Neo, but are largely spared by Gent. n = 9–11 fish, 4 NMs/fish. One-way ANOVA with Dunnet's post-hoc comparison to control, ****P-value < 0.0001. (B) Chronic 24 h treatment with Neo or Gent results in hair cell loss. n = 9–11 fish, 4 NMs/fish. One-way ANOVA with Dunnet's post-hoc comparison to control, ****P-value < 0.0001. (C) Substantial death occurs after 1 h treatment with Neo or Gent, rinsing, and then incubation for 23 h in fresh medium (1+23 h). n = 9–11 fish, 4 NMs/fish. One-way ANOVA with Dunnet's post-hoc comparison to control, ****P-value < 0.0001. (D) Dose-dependent loss of hair cells after treatment with neomycin for 1, 24, or 1+23 h. Differences between treatments were highly significant (2-way ANOVA, Tukey's multiple comparison, p < 0.0005). n = 9–11 fish, 4 NMs/fish for each condition. (E) Dose-dependent loss of hair cells after treatment with gentamicin for 1, 24, or 1+23 h. Differences between treatments were highly significant (2-way ANOVA, Tukey's multiple comparison, p < 0.0001). Post-hoc comparison of individual points are presented in Supplementary Tables 1, 2. n = 9–11 fish, 4 NMs/fish for each condition. Error bars represent Standard Deviation.

To better characterize relative sensitivities, we analyzed dose-response functions of each AG, with concentrations up to 400 μM, using the three experimental paradigms: 1, 1+ 23, or 24 h exposure. For neomycin (Figure 1D), treatment following all three paradigms resulted in substantial and significant dose-dependent damage (2-way ANOVA: p < 0.0001) with significant differences between treatment paradigms (p < 0.0001). While there was a small but reliable increase in sensitivity across the dose-response function from 24 h continuous exposure compared to 1 h acute exposure (Tukey's multiple comparison, p < 0.0001), both treatment paradigms resulted in substantial dose-dependent damage. There were significantly more hair cells present with the 1+23 h paradigm compared to 1 h acute treatment (Tukey's multiple comparison, p = 0.0003). This increase is probably due to the rapid initiation of hair cell regeneration after neomycin washout (21, 58). Treatment with gentamicin (Figure 1E) following all three paradigms also resulted in substantial and significant dose-dependent damage (2-way ANOVA: p < 0.0001), with significant differences between each of the three treatment paradigms (p < 0.0001). While both 24 h and 1+23 treatment paradigms resulted in substantial loss of hair cells, there was nevertheless a large and highly significant difference between these treatments (Tukey's multiple comparison, p < 0.0001). By contrast, treatment for 1 h caused only a slight but significant loss of hair cells across the dose range (1-way ANOVA; p < 0.001).

One way to compare relative efficacy of drug treatments is to calculate the concentration where 50% of hair cells are killed, designated HC50 [(32); Table 1]. For 1 h acute treatment with neomycin, the HC50 is 44 μM, compared to 25 μM for 24 h treatment and 94 μM for 1+23 treatment. For gentamicin, treatment for 24 h was most effective, with an HC50 of 10 μM, and the 1+23 h treatment almost as effective with an HC50 of 19 μM. Treatment with gentamicin for 1 h never approached 50% kill, with only 20% loss at the highest doses. These results demonstrate that differences in the timing of response of hair cells to different AGs persist across the dose-response function.

Table 1

Table 1. HC₅₀ for neomycin and gentamicin under different treatment paradigms.

We next assessed when hair cells were lost during the 23 h incubation period after 1 h gentamicin exposure. We exposed larval fish to gentamicin at concentrations ranging from 25 to 200 μM for 1 h, then rinsed into fresh medium and incubated further for 5, 11, 17, or 23 h before quantifying hair cell loss compared to untreated controls. Figure 2 shows a decline in the number of hair cells over this time period, demonstrating that cells are gradually lost. We observed significant dose-dependent damage (2-way ANOVA: F = 275.9, p < 0.0001) with significant differences between treatment paradigms (F = 118.2, p < 0.0001). The rate of hair cell loss was dependent on the initial concentration of gentamicin present during the 1 h exposure period. While the total hair cell loss assessed at the 24 h endpoint was similar across initial concentrations, hair cell loss varied greatly at intermediate times in a manner dependent on concentration. Treatment with 25 μM gentamicin resulted in little hair cell loss at 11 h following washout, while loss was near completion at that time for 100 and 200 μM gentamicin, and at intermediate levels with 50 μM gentamicin treatment. Overall, there were significant differences in the rate of hair cell death between 25, 50, and 200 μM treatments (Tukey's multiple comparison, p < 0.0001) but not between 100 and 200 μm treatments. However, the final level of cell death by 23 hours after the initial exposure was similar in all groups. These results demonstrate that the rate of delayed death is related to the concentration of gentamicin during the initial exposure.

Figure 2

Figure 2. The rate of delayed hair cell loss is dependent on initial gentamicin concentration. Fish were treated with doses of gentamicin (25, 50, 100, and 200 μM) for 1 h (red bar), then rinsed and incubated in fresh medium (blue bar). Loss of hair cells was assessed at 5, 11, 17, and 23 h after the 1 h incubation period. Increasing initial dose results in more rapid delayed hair cell loss. Differences between 25, 50, and 200 μM treatments were significant (Tukey's multiple comparison, p < 0.0001). There was no significant difference between 100 and 200 μm treatments. n = 9–11 fish, 4 NMs/fish for each treatment. Error bars represent Standard Deviation.

Gentamicin is composed of a number of different structural AG subtypes that have differing levels of ototoxicity (59). We therefore tested whether we observed delayed death using G418, an AG closely related to gentamicin subtypes that can be readily obtained as a single, highly enriched isoform. As for gentamicin, we found that G418 had only a slight effect after 1 h of exposure, while both 24 h and 1+23 treatment paradigms resulted in substantial loss of hair cells (Supplementary Figure 1A; compare to Figure 1E). In addition we found that effects of G418 exposure are influenced by concentration and time of exposure (Supplementary Figure 1B; compare to Figure 2). These results suggests that differences in hair cell death over different concentrations and times of exposure are not caused by overlapping effects of distinct gentamicin isoforms.

Different Ca²⁺ dynamics during acute and delayed hair cell death

We previously reported that acute neomycin exposure to zebrafish lateral line hair cells results in an increase in mitochondrial calcium followed by calcium increase in the cytoplasm, and that these events are necessary and sufficient to activate hair cell degeneration (33, 34). To determine whether similar calcium changes occur during the delayed toxicity described above, we monitored intracellular calcium dynamics in hair cells using targeted, genetically-encoded calcium indicators, as performed previously (33, 34). For these experiments we compared neomycin to G418 to avoid potential complexity of interpretation using the mixture of AGs in gentamicin. We used the green fluorescent GCaMP directed to mitochondria using a CoxVII targeting sequence (mitoGCaMP) and the red indicator RGECO localized to the cytoplasm (cytoRGECO) to measure compartmental calcium levels. We imaged cells under 3 different conditions: after exposure to 100 μM neomycin, where most cells undergo acute death, 100 μM G418, where most cells undergo delayed death, or 400 μM G418, where some cells die under acute conditions and some die with a delayed time course. To capture acute response for treatment with 100 μM neomycin or 400 μM G418, we began imaging immediately after AG addition up to 1 h. To capture delayed responses to treatment with 100 μM G418, fish were incubated in drug for 1 h, rinsed and incubated a further 1.5 h before imaging at 1 min intervals for 2 h. For all treatments, hair cells may die at any time during the imaging period. Changes in fluorescence over time for individual cells were therefore aligned to the same endpoint of cell fragmentation.

Acute treatment with 100 μM neomycin resulted in increases in mitochondrial Ca²⁺ >2 standard deviations over baseline in all dying cells (16/16 dying cells; Figure 3A), consistent with previous results (34). By contrast, we rarely saw similarly large changes in mitochondrial Ca²⁺ when hair cells underwent delayed death after exposure to 100 μM doses of G418 (2/11 dying cells; Figure 3B). We also examined the Ca²⁺ responses in the small fraction of cells that die after acute treatment with 400 μM G418, observing several instances of cells undergoing increases in mitochondrial Ca²⁺ (10/14 dying cells; Figure 3C). The differences in proportion of cells showing a mitochondrial Ca²⁺ signal in each condition is highly significant (Chi-square = 20.25, p < 0.0001). When we compared maximal changes in mitoGCaMP signal in dying cells under the three different AG exposure paradigms (Figure 3D), we found significant differences comparing treatment with 100 μM neomycin to 100 μM G418 (2.2 ± 0.46 vs. 1.2 ± 0.32, Dunn's multiple comparison test, p < 0.0005). When we compared cytoplasmic Ca²⁺ changes using cytoRGECO (Supplementary Figure 2), we found a similar pattern: large changes in cytoplasmic calcium after acute 100 μM neomycin exposure (Supplementary Figure 2A), little or no changes after 100 μM G418 treatment (Supplementary Figure 2B), and intermediate changes in acute 400 μM G418 treatment (Supplementary Figure 2C). When we compared maximal changes in cytoRGECO signal in dying cells under the three different AG exposure paradigms (Supplementary Figure 2D), we found significant differences comparing treatment with 100 μM neomycin to 100 μM G418 (1.8 ± 0.44 vs. 1.2 ± 0.38, Dunn's multiple comparison test, p < 0.0005). Taken together, these experiments further suggest that acute and delayed mechanisms of hair cell death have distinct underlying cellular mechanisms. Moreover, both types of mechanism can be induced by the same AG (here, G418) dependent on exposure concentration and time.

Figure 3

Figure 3. Different mitochondrial Ca²⁺ responses during acute or delayed hair cell death. (A–C) Fish were incubated in AG (red bar) for time indicated, or rinsed into fresh medium (blue bar). Fluorescence changes above baseline (F/F₀) from mitoGCaMP in response to AG addition were monitored at 30 s intervals by spinning disk microscopy over the interval indicated (black bar). Individual traces represent responses of individual cells. Traces are aligned to time of cell fragmentation. (A) Changes in mitoGCaMP signal in cells undergoing acute death in response to 100 μM neomycin. Hair cells were imaged during the 1st h of neomycin exposure. Increases in mitochondrial Ca²⁺ were observed in 16/16 dying cells. (B) Changes in mitoGCaMP signal in cells undergoing delayed death after exposure to 100 μM G418. Cells were exposed to G418 for 1 h followed by rinse and incubation in fresh embryo medium (EM) for 1.5 h, and then imaged over an additional 2 h period. Increases in mitochondrial Ca²⁺ were observed in 2/11 dying cells. (C) Changes in mitoGCaMP signal in cells undergoing acute death in response to 400 μM G418. Hair cells were imaged during the 1st h of G418 exposure. Increases in mitochondrial Ca²⁺ were observed in 10/14 dying cells. (D) Maximum mitoGCaMP signal compared to baseline for dying cells after neomycin or G418 exposure. P-values from Kruskal-Wallis with Dunn's multiple comparison test. Error bars represent Standard Deviation.

Mitochondrial calcium uptake after neomycin exposure results in production of reactive oxygen species (ROS), and treatment with mitochondria-targeted antioxidant mitoTEMPO partially protects hair cells from neomycin damage (36). We therefore tested whether mitoTEMPO could ameliorate effects of acute and delayed mechanisms of hair cell death (Figure 4). We found that 50 μM mitoTEMPO treatment conferred significant protection against 1 h exposure to 100 or 200 μM neomycin (Figure 4A; Sidak multiple comparison test, p < 0.0001), consistent with our previous study. By contrast we observed no protection against 100 or 200 μM G418 using the 1+23 h exposure paradigm (Figure 4B). We also found that mitoTEMPO protected against high doses of acute (1 h) G418 exposure (Supplementary Figure 3). Treatment with mitoTEMPO did not block uptake of either neomycin or G418 (Supplementary Figure 4). These results support the idea that delayed cell death uses mechanisms that are distinct from those underlying acute cell death.

Figure 4

Figure 4. The mitochondrially-targeted antioxidant mitoTEMPO protects against acute neomycin damage from neomycin but not delayed damage from G418. 50 μM mitoTEMPO was added for 30 min before AG (purple bar), co-treated with neomycin for 1 h or co-treated with G418 for 1 h (red bar), rinsed, and incubated with mitoTEMPO alone for 23 h (purple bar). (A) mitoTEMPO partially protected against damage from both 100 and 200 μM neomycin treatment. ****Two-way ANOVA, Sidak's multiple comparison, p < 0.0001. (B) mitoTEMPO offered no protection against damage from either 100 or 200 μM G418 treatment. ns Two-way ANOVA, Sidak's multiple comparison, p = 0.98. n = 9–11 fish, 4 NMs/fish for each treatment group. Error bars represent Standard Deviation.

Intracellular distribution of AG after washout

To begin identifying cellular pathways underlying the delayed death seen following gentamicin exposure, we examined more closely the cellular distribution of AGs at different times of exposure. For these experiments, we conjugated the red fluorescent dye Texas Red to neomycin (Neo-TR) or G418 (G418-TR) to follow entry and accumulation of AGs into hair cells. Neo-TR and G418-TR showed dose-dependent toxicity that was indistinguishable from the unconjugated forms (Supplementary Figure 5). To identify endolysosomal accumulation, we created a transgenic line where the small GTPase Rab7, a marker of late endosomes and lysosomes (60), was conjugated to GFP and expressed under the hair cell-specific myosin6b promoter (Figure 5). We previously reported that neomycin showed broad cytoplasmic distribution while gentamicin was sequestered to puncta (61). Here we see a similar pattern: after 5 min exposure, G418-TR is enriched within vesicles (Figure 5A), while Neo-TR shows diffuse distribution as well as some accumulation in Rab7-GFP+ vesicles (Figure 5B). To quantify the relative accumulation of AG in Rab7 vesicles, we used a semi-automated algorithm to segment the Rab7-GFP signal. We then measured Neo-TR or G418-TR fluorescence within the Rab7 compartment and compared it to TR fluorescence throughout the hair cell cytoplasm (Supplementary Figure 6). There was no significant difference between the number of vesicles segmented between the two conditions (Supplementary Figure 6B). Overall, the fluorescence signal was stronger in both compartments comparing Neo-TR to G418-TR (Supplementary Figures 6C, D), due to differences in labeling efficiency of each AG. When we compared the ratio of AG-TR fluorescence in Rab7 vesicles compared to the cytoplasm, we found that the ratio for G418-TR was significantly higher than that for Neo-TR (Figure 5C). These results suggest that differential accumulation of the distinct AGs into different compartments might underlie the distinct mechanisms of cell death observed after treatment.

Figure 5

Figure 5. Neomycin and G418 differentially accumulate in Rab7+ vesicles. (A) G418-TR (magenta) accumulation in Rab7+ vesicles (green) in neuromast from Tg(myosin6b:EGFP-Rab7a) transgenic line. (A') G418-TR signal is mainly in vesicles. (B) Neo-TR (magenta) accumulation in Rab7+ vesicles (green) in neuromast from Tg(myosin6b:EGFP-Rab7a) transgenic line. (B') Neo-TR signal is found in vesicles and cytoplasm. (C) Ratio of G418-TR and Neo-TR found in Rab7+ vesicles compared to cytoplasm. Shading indicates measurements from three separate experiments. **Unpaired T-test, p < 0.01. Error bars represent Standard Deviation.

Altering endolysosomal function protects against delayed but not acute hair cell death

To further explore the idea that endolysosomal localization plays a central role in the different mechanisms of hair cell death, we treated hair cells with glycyl-L-phenylalanine 2-naphthylamide (GPN), a di-peptide that accumulates in lysosomes and disrupts their function (62–64). To assess the effects of GPN on the distribution of G418, we measured the accumulation of G418-TR in vesicles in control animals or those pre-treated with 250 μM GPN for 1 h and then co-treating with 50 μM G418-TR for 1 h (Figure 6). We used semi-automated algorithms to segment hair cell bodies (Figures 6A′, B′) and G418+ puncta (Figures 6A^′′, B^′′). We found that GPN treatment significantly reduced the number of vesicles containing G418-TR (Figure 6C, Mann-Whitney test, p < 0.0001). By contrast, the mean vesicle volume per neuromast (Figure 6D) or mean vesicle fluorescence (Figure 6E) remained unchanged. Moreover, the total fluorescence of G418-TR per neuromast was unchanged, suggesting that GPN influences the intracellular distribution of G418 but does not block uptake into hair cells.

Figure 6

Figure 6. GPN treatment reduces the number of vesicles accumulating G418. (A) Image of neuromast treated with G418-TR. (A') Mask of segmented hair cells. (A”) Mask of segmented vesicles. (B) Image of neuromast treated with G418-TR and GPN. (B') Mask of segmented hair cells. (B”) Mask of segmented vesicles. (C) Number of vesicles per hair cell, mean for each neuromast analyzed. ****Mann-Whitney test, p < 0.0001. (D) Vesicle volume per hair cell, mean for each neuromast. ns, Mann-Whitney test. (E) Vesicle fluorescence per hair cell, mean for each neuromast analyzed. ns, Mann-Whitney test. Error bars represent Standard Deviation.

We next compared the effects of GPN treatment on toxicity due to exposure to neomycin or gentamicin. We assessed whether GPN altered delayed damage after gentamicin treatment by pre-treating with 250 μM GPN for 1 h, co-treating with gentamicin at different concentrations, rinsing with fresh medium, and incubating in 250 μM GPN alone for an additional 23 h (Figure 7A). GPN treatment offered robust protection from delayed death at all concentrations tested (Two-way ANOVA, Sidak multiple comparison, p < 0.0001). We also assessed acute damage from neomycin after 1 h GPN pre-treatment and 1 h neomycin co-treatment (Figure 7B). Across all doses of neomycin, we found GPN treatment offered no protection. We also tested whether the vacuolar ATPase inhibitor bafilomycin A1, a well-characterized inhibitor of lysosomal function (65), alters AG susceptibility (Supplementary Figure 7). Treatment with 100 nM bafilomycin A1 offered robust protection against gentamicin with significant differences at all concentrations (two-way ANOVA, Sidak multiple comparison, p < 0.0001 for 25–100 μM, p < 0.005 for 200 μM). Like GPN, bafilomycin offered no protection against neomycin. Finally, we tested whether treatment with these lysosomal drugs affected the overall uptake of fluorescent AG into hair cells (Supplementary Figure 8). Bafilomycin A1 significantly reduced G418-TR uptake (Mann Whitney test, p < 0.0001). However, GPN treatment had no effect on the overall accumulation of G418-TR. Taken together, these results support a model where differential accumulation into the endolysosomal compartment leads to distinct mechanisms of hair cell death.

Figure 7

Figure 7. GPN treatment protects against delayed gentamicin damage but not acute neomycin damage. 250 μM GPN was added for 30 min before AG (purple bar), co-treated with neomycin for 1 h or co-treated with G418 for 1 h (red bar), rinsed, and incubated with GPN alone for 23 h (purple bar). (A) GPN treatment offers robust protection against delayed death from all concentrations of gentamicin (Two-way ANOVA, Sidak's multiple comparison, p < 0.0001). (B) GPN does not protect against acute death from neomycin at any concentration. n = 9–11 fish, 4 NMs/fish for each treatment group. Error bars represent Standard Deviation.

Discussion

In this study, we describe experiments that reveal at least two different mechanisms by which AGs kill zebrafish lateral line hair cells that can be distinguished by the time of exposure and the type of AG: we observed acute death within minutes of exposure to neomycin, but delayed death after washout exposure to gentamicin or G418. We provide evidence that these distinct mechanisms of acute or delayed death are regulated by different intracellular processes. We previously described an acute series of events through which a breakdown in inter-organellar Ca²⁺ exchange results in mitochondrial collapse within minutes of neomycin exposure (33, 34, 36). Here we observed only rare instances of Ca²⁺ increases in either cytoplasmic or mitochondrial compartments before cell fragmentation during delayed death after G418 exposure. Consistent with these results, the mitochondria-targeted antioxidant mitoTEMPO protected against acute death from neomycin but had little effect on delayed hair cell death from G418 exposure. We also demonstrated that using very high doses of G418 can result in acute death with accompanying Ca²⁺ increases, indicating that the same AG can kill cells by acute or delayed mechanisms dependent on time and exposure concentrations. Finally, we show that endolysosomal accumulation of AG correlates with whether cells will undergo delayed death, and interfering with the endolysosomal compartment with the di-peptide drug GPN protects against delayed death but not acute death. Together, these results suggest that AGs engage different cell death pathways with distinct spatial and temporal dynamics.

The underlying mechanisms by which lysosomal accumulation of AGs result in delayed cell death remain unclear. We found that GPN treatment reduced the number of vesicles containing labeled G418 as well as protecting against delayed hair cell death, raising the possibility that sequestration is the cause of the delay, and subsequent release of AG from lysosomes results in hair cell death. However, differences in calcium dynamics accompanying acute and delayed death suggest that downstream events still diverge with the different AG treatments. Another possible mechanism is that lysosomal accumulation of AGs eventually promotes lysosomal membrane permeabilization (LMP) and cell death [reviewed in Wang et al. (66)]. Several potential mechanisms lie downstream of LMP, including capthepsin-mediated cell death, changes in iron metabolism resulting in ferroptosis, or inflammasome activation resulting in pyroptosis. Work over the past decade has revealed that lysosomes function as more than just waste storage, but act as signaling hubs for nutrient sensing, lipid metabolism, and intraorganellar contacts (67); disruption of these processes by AGs may also contribute to hair cell death. GPN has long been used to disrupt lysosomal function [reviewed in Morgan et al. (68)], however the consequences of GPN treatment can vary depending on context. After its cleavage by lysosomal cathepsin proteases, GPN can promote LMP, altering lysosomal calcium signaling and pH (69). GPN can also promote release of calcium from the ER, potentially independent of lysosomal pH changes (70). Future work will require genetic and pharmacological interventions to identify whether these pathways act downstream of lysosomal AG accumulation.

Our previous study suggested that AGs accumulate in lysosomes in zebrafish lateral line hair cells by autophagy, as treatment with the inhibitor 3-methyadenine (3MA) blocked vesicular localization (61). 3MA was also effective at preventing AG-induced cell death in zebrafish (71). In mouse cochlea, AG binding to the Rho-family interacting protein RIPOR2, activates autophagy and mitophagy via PINK/Parkin, and genetic inactivation of autophagy/mitophagy components protects hair cells from damage (72). By contrast pharmacologic manipulation of autophagy suggests that it protects against AG induced hair cell death (73, 74). Screening a library of drugs that alter autophagy had mixed results, with some compounds offering protection while others showing toxicity (75). As a whole, these results suggest complex interactions between autophagy and AG toxicity, in part reflecting the underlying complexity of the autophagy network of signaling interactions.

Taken together, our work describes two distinct mechanisms of hair cell death in the zebrafish lateral line following two different routes through the cell, engaging either mitochondria or lysosomes. More broadly, many mechanisms have been previously described to underlie AG-induced hair cell death. These include caspase-dependent and caspase-independent apoptotic like processes (76–79), ribotoxic stress pathways (80) and necroptosis (81). AGs may damage hair cells by directly interfering with mitochondrial ribosomal translation (82–86) or bioenergetics (87). AGs have also been described to preferentially interact with phosphoinositide lipids (88), with multiple potential downstream consequences (89–92). To what degree these processes intersect with the mitochondrial and lysosomal pathways remains an active area of interest.

We propose that engagement of different mechanisms of cell death depends on the type of AG, concentration, duration of exposure and potentially additional factors such as hair cell type, genetic factors and exposure to previous environmental insults. Neomycin and gentamicin belong to structurally distinct classes of AGs; future studies will explore whether there is a structure-activity relationship between AG class and timing of death. The potential for activation of multiple distinct cell death pathways to varying degrees in response to different AGs has important consequences for the design of therapeutic approaches to prevent AG-induced ototoxicity [reviewed in Kim et al. (93) and Hsieh et al. (94)]. It suggests that targeting specific downstream pathways may have limited success in preventing damage, as other mechanisms may bypass the intervention. This may explain the limited efficacy that blocking reactive oxygen species has had in preventing damage from ototoxins. It also suggests that approaches to develop compounds that block common early steps such as AG entry into hair cells (31, 32, 95, 96) or modifications of AGs to reduce hair cell uptake (97), may be promising directions for future therapy.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The animal study was approved by the University of Washington Institutional Animal Care and Use Committee. The study was conducted in accordance with the local legislation and institutional requirements.

Author contributions

PW: Conceptualization, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing. FB-B: Formal analysis, Investigation, Methodology, Software, Visualization, Writing – review & editing. RO: Investigation, Methodology, Visualization, Writing – review & editing. EC: Formal analysis, Investigation, Methodology, Visualization, Writing – review & editing. TL: Investigation, Methodology, Writing – review & editing. JS: Conceptualization, Formal analysis, Supervision, Writing – review & editing. ER: Conceptualization, Formal analysis, Supervision, Writing – review & editing. DR: Conceptualization, Data curation, Funding acquisition, Project administration, Supervision, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by an Emerging Research Grant from the Hearing Health Foundation to FBB and a grant from the National Institutes on Deafness and Other Communication Disorders (R01 DC05987) to DR.

Acknowledgments

We thank David White, the UW Zebrafish Facility for excellent fish care, and Ananya Cholkar for superior technical help.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2024.1480435/full#supplementary-material

References

1. Friedman LM, Dror AA, Avraham KB. Mouse models to study inner ear development and hereditary hearing loss. Int J Dev Biol. (2007) 51:609–31. doi: 10.1387/ijdb.072365lf

PubMed Abstract | Crossref Full Text | Google Scholar

2. Angeli S, Lin X, Liu XZ. Genetics of hearing and deafness. Anat Rec. (2012) 295:1812–29. doi: 10.1002/ar.22579

PubMed Abstract | Crossref Full Text | Google Scholar

3. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. (2007) 15:52–7. doi: 10.1097/MOO.0b013e3282ef772d

PubMed Abstract | Crossref Full Text | Google Scholar

4. Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Mechanisms of cisplatin-induced ototoxicity and otoprotection. Front Cell Neurosci. (2017) 11:338. doi: 10.3389/fncel.2017.00338

PubMed Abstract | Crossref Full Text | Google Scholar

5. Jiang M, Karasawa T, Steyger PS. Aminoglycoside-induced cochleotoxicity: a review. Front Cell Neurosci. (2017) 11:308. doi: 10.3389/fncel.2017.00308

PubMed Abstract | Crossref Full Text | Google Scholar

6. O'Sullivan ME, Perez A, Lin R, Sajjadi A, Ricci AJ, Cheng AG. Towards the prevention of aminoglycoside-related hearing loss. Front Cell Neurosci. (2017) 11:325. doi: 10.3389/fncel.2017.00325

PubMed Abstract | Crossref Full Text | Google Scholar

7. van Altena R, Dijkstra JA, van der Meer ME, Borjas Howard JF, Kosterink JG, van Soolingen D, et al. Reduced chance of hearing loss associated with therapeutic drug monitoring of aminoglycosides in the treatment of multidrug-resistant tuberculosis. Antimicrob Agents Chemother. (2017) 61:e01400–16. doi: 10.1128/AAC.01400-16

PubMed Abstract | Crossref Full Text | Google Scholar

8. Heysell SK, Ahmed S, Rahman MT, Akhanda MW, Gleason AT, Ebers A, et al. Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh. Eur Respir J. (2018) 51:1701778. doi: 10.1183/13993003.01778-2017

PubMed Abstract | Crossref Full Text | Google Scholar

9. Dillard LK, Martinez RX, Perez LL, Fullerton AM, Chadha S, McMahon CM. Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: a systematic review. J Infect. (2021) 83:27–36. doi: 10.1016/j.jinf.2021.05.010

PubMed Abstract | Crossref Full Text | Google Scholar

10. Scheenstra RJ, Rijntjes E, Tavy DL, Kingma H, Heijerman HG. Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients. Acta Otolaryngol. (2009) 129:4–7. doi: 10.1080/00016480801968534

PubMed Abstract | Crossref Full Text | Google Scholar

11. Garinis AC, Cross CP, Srikanth P, Carroll K, Feeney MP, Keefe DH, et al. The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis. J Cyst Fibros. (2017) 16:401–9. doi: 10.1016/j.jcf.2017.01.006

PubMed Abstract | Crossref Full Text | Google Scholar

12. Garinis A, Gleser M, Johns A, Larsen E, Vachhani J. Prospective cohort study of ototoxicity in persons with cystic fibrosis following a single course of intravenous tobramycin. J Cyst Fibros. (2021) 20:278–83. doi: 10.1016/j.jcf.2020.07.001

PubMed Abstract | Crossref Full Text | Google Scholar

13. Zettner EM, Gleser MA. Progressive hearing loss among patients with cystic fibrosis and parenteral aminoglycoside treatment. Otolaryngol Head Neck Surg. (2018) 159:887–94. doi: 10.1177/0194599818782444

PubMed Abstract | Crossref Full Text | Google Scholar

14. Handelsman JA, Nasr SZ, Pitts C, King WM. Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides. Pediatr Pulmonol. (2017) 52:1157–62. doi: 10.1002/ppul.23763

PubMed Abstract | Crossref Full Text | Google Scholar

15. Prasad K, Borre ED, Dillard LK, Ayer A, Der C, Bainbridge KE, et al. (2024). Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review. Lancet Glob Health. 12:e217–25. doi: 10.1016/S2214-109X(23)00514-4

PubMed Abstract | Crossref Full Text | Google Scholar

16. Stawicki TM, Esterberg R, Hailey DW, Raible DW, Rubel EW. Using the zebrafish lateral line to uncover novel mechanisms of action and prevention in drug-induced hair cell death. Front Cell Neurosci. (2015) 9:46. doi: 10.3389/fncel.2015.00046

PubMed Abstract | Crossref Full Text | Google Scholar

17. Coffin AB, Ramcharitar J. Chemical ototoxicity of the fish inner ear and lateral line. Adv Exp Med Biol. (2016) 877:419–37. doi: 10.1007/978-3-319-21059-9_18

PubMed Abstract | Crossref Full Text | Google Scholar

18. Nicolson T. The genetics of hair-cell function in zebrafish. J Neurogenet. (2017) 31:102–12. doi: 10.1080/01677063.2017.1342246

PubMed Abstract | Crossref Full Text | Google Scholar

19. Kindt KS, Sheets L. Transmission disrupted: modeling auditory synaptopathy in zebrafish. Front Cell Dev Biol. (2018) 6:114. doi: 10.3389/fcell.2018.00114

PubMed Abstract | Crossref Full Text | Google Scholar

20. Pickett SB, Raible DW. Water waves to sound waves: using zebrafish to explore hair cell biology. JARO. (2019) 20:1–19. doi: 10.1007/s10162-018-00711-1

PubMed Abstract | Crossref Full Text | Google Scholar

21. Harris JA, Cheng AG, Cunningham LL, MacDonald G, Raible DW, Rubel EW. Neomycin-induced hair cell death in the lateral line of zebrafish (Danio rerio): a model system to study hair cell survival. JARO. (2003) 4:219–34. doi: 10.1007/s10162-002-3022-x

PubMed Abstract | Crossref Full Text | Google Scholar

22. Ton C, Parng C. The use of zebrafish for assessing ototoxic and otoprotective agents. Hear Res. (2005) 208:79–88. doi: 10.1016/j.heares.2005.05.005

PubMed Abstract | Crossref Full Text | Google Scholar

23. Ou HC, Raible DW, Rubel EW. Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line. Hear Res. (2007) 233:46–53. doi: 10.1016/j.heares.2007.07.003

PubMed Abstract | Crossref Full Text | Google Scholar

24. Chiu LL, Cunningham LL, Raible DW, Rubel EW, Ou HC. Using the zebrafish lateral line to screen for ototoxicity. J Assoc Res Otolaryngol. (2008) 9:178–90. doi: 10.1007/s10162-008-0118-y

PubMed Abstract | Crossref Full Text | Google Scholar

25. Hirose Y, Simon JA, Ou HC. Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral line. J Assoc Res Otolaryngol. (2011) 12:719–28. doi: 10.1007/s10162-011-0278-z

PubMed Abstract | Crossref Full Text | Google Scholar

26. Neveux S, Smith NK, Roche A, Blough BE, Pathmasiri W, Coffin AB. Natural compounds as occult ototoxins? Ginkgo biloba flavonoids moderately damage lateral line hair cells. J Assoc Res Otolaryngol. (2017) 18:275–89. doi: 10.1007/s10162-016-0604-6

PubMed Abstract | Crossref Full Text | Google Scholar

27. Coffin AB, Boney R, Hill J, Tian C, Steyger PS. Detecting novel ototoxins and potentiation of ototoxicity by disease settings. Front Neurol. (2021) 12:725566. doi: 10.3389/fneur.2021.725566

PubMed Abstract | Crossref Full Text | Google Scholar

28. Davis SN, Wu P, Camci ED, Simon JA, Rubel EW, Raible DW. Chloroquine kills hair cells in Zebrafish lateral line and murine cochlear cultures: implications for ototoxicity. Hear Res. (2020) 395:108019. doi: 10.1016/j.heares.2020.108019

PubMed Abstract | Crossref Full Text | Google Scholar

29. Owens KN, Santos F, Roberts B, Linbo T, Coffin AB, Knisely AJ, et al. Identification of genetic and chemical modulators of zebrafish mechanosensory hair cell death. PLoS Genet. (2008) 4:e1000020. doi: 10.1371/journal.pgen.1000020

PubMed Abstract | Crossref Full Text | Google Scholar

30. Vlasits AL, Simon JA, Raible DW, Rubel EW, Owens KN. Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin. Hear Res. (2012) 294:153–65. doi: 10.1016/j.heares.2012.08.002

PubMed Abstract | Crossref Full Text | Google Scholar

31. Kenyon EJ, Kirkwood NK, Kitcher SR, O'Reilly M, Derudas M, Cantillon DM, et al. Identification of ion-channel modulators that protect against aminoglycoside-induced hair cell death. JCI Insight. (2017) 2:96773. doi: 10.1172/jci.insight.96773

PubMed Abstract | Crossref Full Text | Google Scholar

32. Chowdhury S, Owens KN, Herr RJ, Jiang Q, Chen X, Johnson G, et al. Phenotypic optimization of urea-thiophene carboxamides to yield potent, well tolerated, and orally active protective agents against aminoglycoside-induced hearing loss. J Med Chem. (2018) 61:84–97. doi: 10.1021/acs.jmedchem.7b00932

PubMed Abstract | Crossref Full Text | Google Scholar

33. Esterberg R, Hailey DW, Coffin AB, Raible DW, Rubel EW. Disruption of intracellular calcium regulation is integral to aminoglycoside-induced hair cell death. J Neurosci. (2013) 33:7513–25. doi: 10.1523/JNEUROSCI.4559-12.2013

PubMed Abstract | Crossref Full Text | Google Scholar

34. Esterberg R, Hailey DW, Rubel EW, Raible DW. ER-mitochondrial calcium flow underlies vulnerability of mechanosensory hair cells to damage. J Neurosci. (2014) 34:9703–19. doi: 10.1523/JNEUROSCI.0281-14.2014

PubMed Abstract | Crossref Full Text | Google Scholar

35. Owens KN, Cunningham DE, MacDonald G, Rubel EW, Raible DW, Pujol R. Ultrastructural analysis of aminoglycoside-induced hair cell death in the zebrafish lateral line reveals an early mitochondrial response. J Comp Neurol. (2007) 502:522–43. doi: 10.1002/cne.21345

PubMed Abstract | Crossref Full Text | Google Scholar

36. Esterberg R, Linbo T, Pickett SB, Wu P, Ou HC, Rubel EW, et al. Mitochondrial calcium uptake underlies ROS generation during aminoglycoside-induced hair cell death. J Clin Invest. (2016) 126:3556–66. doi: 10.1172/JCI84939

PubMed Abstract | Crossref Full Text | Google Scholar

37. Owens KN, Coffin AB, Hong LS, Bennett KO, Rubel EW, Raible DW. Response of mechanosensory hair cells of the zebrafish lateral line to aminoglycosides reveals distinct cell death pathways. Hear Res. (2009) 253:32–41. doi: 10.1016/j.heares.2009.03.001

PubMed Abstract | Crossref Full Text | Google Scholar

38. Coffin AB, Rubel EW, Raible DW. Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line. J Assoc Res Otolaryngol. (2013) 14:645–59. doi: 10.1007/s10162-013-0404-1

PubMed Abstract | Crossref Full Text | Google Scholar

39. Maeda R, Kindt KS, Mo W, Morgan CP, Erickson T, Zhao H, et al. Tip-link protein protocadherin 15 interacts with transmembrane channel-like proteins TMC1 and TMC2. Proc Natl Acad Sci USA. (2014) 111:12907–12. doi: 10.1073/pnas.1402152111

PubMed Abstract | Crossref Full Text | Google Scholar

40. Xiao T, Roeser T, Staub W, Baier H. A GFP-based genetic screen reveals mutations that disrupt the architecture of the zebrafish retinotectal projection. Development. (2005) 132:2955–67. doi: 10.1242/dev.01861

PubMed Abstract | Crossref Full Text | Google Scholar

41. Kawakami K, Shima A, Kawakami N. Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage. Proc Natl Acad Sci U S A. (2000) 97:11403–8. doi: 10.1073/pnas.97.21.11403

PubMed Abstract | Crossref Full Text | Google Scholar

42. Kindt KS, Finch G, Nicolson T. Kinocilia mediate mechanosensitivity in developing zebrafish hair cells. Dev Cell. (2012) 23:329–41. doi: 10.1016/j.devcel.2012.05.022

PubMed Abstract | Crossref Full Text | Google Scholar

43. Clark BS, Winter M, Cohen AR, Link BA. Generation of Rab-based transgenic lines for in vivo studies of endosome biology in zebrafish. Dev Dyn. (2011) 240:2452–65. doi: 10.1002/dvdy.22758

PubMed Abstract | Crossref Full Text | Google Scholar

44. Sandoval R, Leiser J, Molitoris BA. Aminoglycoside antibiotics traffic to the Golgi complex in LLC-PK1 cells. J Am Soc Nephrol. (1998) 9:167–74. doi: 10.1681/ASN.V92167

PubMed Abstract | Crossref Full Text | Google Scholar

45. Steyger PS, Peters SL, Rehling J, Hordichok A, Dai CF. Uptake of gentamicin by bullfrog saccular hair cells in vitro. J Assoc Res Otolaryngol. (2003) 4:565–78. doi: 10.1007/s10162-003-4002-5

PubMed Abstract | Crossref Full Text | Google Scholar

46. Stawicki TM, Owens KN, Linbo T, Reinhart KE, Rubel EW, Raible DW. The zebrafish merovingian mutant reveals a role for pH regulation in hair cell toxicity and function. Dis Model Mech. (2014) 7:847–56. doi: 10.1242/dmm.016576

PubMed Abstract | Crossref Full Text | Google Scholar

47. Raible DW, Kruse GJ. Organization and development of the lateral line system in embryonic zebrafish. J Comp Neurol. (2000) 421:189–98. doi: 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K

Crossref Full Text | Google Scholar

48. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. (2012) 9:676–82. doi: 10.1038/nmeth.2019

PubMed Abstract | Crossref Full Text | Google Scholar

49. Hewitt MN, Cruz IA, Raible DW. Spherical harmonics analysis reveals cell shape-fate relationships in zebrafish lateral line neuromasts. Development. (2024) 151:dev202251. doi: 10.1242/dev.202251

PubMed Abstract | Crossref Full Text | Google Scholar

50. Thévenaz P, Ruttimann UE, Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans Image Process. (1998) 7:27–41. doi: 10.1109/83.650848

PubMed Abstract | Crossref Full Text | Google Scholar

51. Zack GW, Rogers WE, Latt SA. Automatic measurement of sister chromatid exchange frequency. J Histochem Cytochem. (1977) 25:741–53. doi: 10.1177/25.7.70454

PubMed Abstract | Crossref Full Text | Google Scholar

52. Van Der Walt S, Schönberger JL, Nunez-Iglesias J, Boulogne F, Warner JD, Yager N, et al. scikit-image: image processing in Python. PeerJ. (2014) 2:453. doi: 10.7717/peerj.453

PubMed Abstract | Crossref Full Text | Google Scholar

53. Liao PS, Chen TS, Chung PC. A fast algorithm for multilevel thresholding. J Inf Sci Eng. (2001) 17:713–27.

Google Scholar

54. Sauvola J, Pietikäinen M. Adaptive document image binarization. Pattern Recognit. (2000) 33:225–36. doi: 10.1016/S0031-3203(99)00055-2

Crossref Full Text | Google Scholar

55. Sofroniew N, Lambert T, Evans K, Nunez-Iglesias J, Bokota G, Winston P, et al. Napari: a Multi-dimensional Image Viewer for Python (2022). doi: 10.5281/zenodo.3555620

Crossref Full Text | Google Scholar

56. Chen J, Ding L, Viana MP, Lee H, Sluezwski MF, Morris B, et al. The Allen Cell and Structure Segmenter: a new open source toolkit for segmenting 3D intracellular structures in fluorescence microscopy images. bioRxiv. (2018) 2018:491035. doi: 10.1101/491035

Crossref Full Text | Google Scholar

57. Wu K, Otoo E, Shoshani A. Optimizing connected component labeling algorithms. Med Imaging. (2005) 2005:1965. doi: 10.1117/12.596105

Crossref Full Text | Google Scholar

58. Ma EY, Rubel EW, Raible DW. Notch signaling regulates the extent of hair cell regeneration in the zebrafish lateral line. J Neurosci. (2008) 28:2261–73. doi: 10.1523/JNEUROSCI.4372-07.2008

PubMed Abstract | Crossref Full Text | Google Scholar

59. O'Sullivan ME, Song Y, Greenhouse R, Lin R, Perez A, Atkinson PJ, et al. Dissociating antibacterial from ototoxic effects of gentamicin C-subtypes. Proc Natl Acad Sci USA. (2020) 117:32423–32. doi: 10.1073/pnas.2013065117

PubMed Abstract | Crossref Full Text | Google Scholar

60. Langemeyer L, Fröhlich F, Ungermann C. Rab GTPase function in endosome and lysosome biogenesis. Trends Cell Biol. (2018) 28:957–70. doi: 10.1016/j.tcb.2018.06.007

PubMed Abstract | Crossref Full Text | Google Scholar

61. Hailey DW, Esterberg R, Linbo TH, Rubel EW, Raible DW. Fluorescent aminoglycosides reveal intracellular trafficking routes in mechanosensory hair cells. J Clin Invest. (2017) 127:472–86. doi: 10.1172/JCI85052

PubMed Abstract | Crossref Full Text | Google Scholar

62. Jadot M, Colmant C, Wattiaux-De Coninck S, Wattiaux R. Intralysosomal hydrolysis of glycyl-L-phenylalanine 2-naphthylamide. Biochem J. (1984) 219:965–70. doi: 10.1042/bj2190965

PubMed Abstract | Crossref Full Text | Google Scholar

63. Jadot M, Biélande V, Beauloye V, Wattiaux-De Coninck S, Wattiaux R. Cytotoxicity and effect of glycyl-D-phenylalanine-2-naphthylamide on lysosomes. Biochim Biophys Acta. (1990) 1027:205–9. doi: 10.1016/0005-2736(90)90086-4

PubMed Abstract | Crossref Full Text | Google Scholar

64. Berg TO, Strømhaug E, Løvdal T, Seglen O, Berg T. Use of glycyl-L-phenylalanine 2-naphthylamide, a lysosome-disrupting cathepsin C substrate, to distinguish between lysosomes and prelysosomal endocytic vacuoles. Biochem J. (1994) 300:229–36. doi: 10.1042/bj3000229

PubMed Abstract | Crossref Full Text | Google Scholar

65. Bowman EJ, Siebers A, Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA. (1988) 85:7972–6. doi: 10.1073/pnas.85.21.7972

PubMed Abstract | Crossref Full Text | Google Scholar

66. Wang F, Gómez-Sintes R, Boya P. Lysosomal membrane permeabilization and cell death. Traffic. (2018) 19:918–31. doi: 10.1111/tra.12613

PubMed Abstract | Crossref Full Text | Google Scholar

67. Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. (2020) 21:101–18. doi: 10.1038/s41580-019-0185-4

PubMed Abstract | Crossref Full Text | Google Scholar

68. Morgan AJ, Yuan Y, Patel S, Galione A. Does lysosomal rupture evoke Ca²⁺ release? a question of pores and stores. Cell Calcium. (2020) 86:102139. doi: 10.1016/j.ceca.2019.102139

PubMed Abstract | Crossref Full Text | Google Scholar

69. Yuan Y, Kilpatrick BS, Gerndt S, Bracher F, Grimm C, Schapira AH, et al. The lysosomotrope GPN mobilises Ca²⁺ from acidic organelles. J Cell Sci. (2021) 134:jcs256578. doi: 10.1242/jcs.256578

PubMed Abstract | Crossref Full Text | Google Scholar

70. Atakpa P, van Marrewijk LM, Apta-Smith M, Chakraborty S, Taylor CW. GPN does not release lysosomal Ca²⁺ but evokes Ca²⁺ release from the ER by increasing the cytosolic pH independently of cathepsin C. J Cell Sci. (2019) 32:jcs223883. doi: 10.1242/jcs.223883

PubMed Abstract | Crossref Full Text | Google Scholar

71. Coffin AB, Williamson KL, Mamiya A, Raible DW, Rubel EW. Profiling drug-induced cell death pathways in the Zebrafish lateral line. Apoptosis. (2013) 18:393–408. doi: 10.1007/s10495-013-0816-8

PubMed Abstract | Crossref Full Text | Google Scholar

72. Li J, Liu C, Müller U, Zhao B. RIPOR2-mediated autophagy dysfunction is critical for aminoglycoside-induced hearing loss. Dev Cell. (2022) 57:2204–20. doi: 10.1016/j.devcel.2022.08.011

PubMed Abstract | Crossref Full Text | Google Scholar

73. He Z, Guo L, Shu Y, Fang Q, Zhou H, Liu Y, et al. Autophagy protects auditory hair cells against neomycin-induced damage. Autophagy. (2017) 13:1884–904. doi: 10.1080/15548627.2017.1359449

PubMed Abstract | Crossref Full Text | Google Scholar

74. Zhang Y, Fang Q, Wang H, Qi J, Sun S, Liao M, et al. Increased mitophagy protects cochlear hair cells from aminoglycoside-induced damage. Autophagy. (2023) 19:75–91. doi: 10.1080/15548627.2022.2062872

PubMed Abstract | Crossref Full Text | Google Scholar

75. Draf C, Wyrick T, Chavez E, Pak K, Kurabi A, Leichtle A, et al. A screen of autophagy compounds implicates the proteasome in mammalian aminoglycoside-induced hair cell damage. Front Cell Dev Biol. (2021) 9:762751. doi: 10.3389/fcell.2021.762751

PubMed Abstract | Crossref Full Text | Google Scholar

76. Forge A, Li L. Apoptotic death of hair cells in mammalian vestibular sensory epithelia. Hear Res. (2000) 139:97–115. doi: 10.1016/S0378-5955(99)00177-X

PubMed Abstract | Crossref Full Text | Google Scholar

77. Cunningham LL, Cheng AG, Rubel EW. Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci. (2002) 22:8532–40. doi: 10.1523/JNEUROSCI.22-19-08532.2002

PubMed Abstract | Crossref Full Text | Google Scholar

78. Matsui JI, Ogilvie JM, Warchol ME. Inhibition of caspases prevents ototoxic and ongoing hair cell death. J Neurosci. (2002) 22:1218–27. doi: 10.1523/JNEUROSCI.22-04-01218.2002

PubMed Abstract | Crossref Full Text | Google Scholar

79. Jiang H, Sha SH, Forge A, Schacht J. Caspase-independent pathways of hair cell death induced by kanamycin in vivo. Cell Death Differ. (2006) 13:20–30. doi: 10.1038/sj.cdd.4401706

PubMed Abstract | Crossref Full Text | Google Scholar

80. Francis SP, Katz J, Fanning KD, Harris KA, Nicholas BD, Lacy M, et al. A novel role of cytosolic protein synthesis inhibition in aminoglycoside ototoxicity. J Neurosci. (2013) 33:3079–93. doi: 10.1523/JNEUROSCI.3430-12.2013

PubMed Abstract | Crossref Full Text | Google Scholar

81. Ruhl D, Du TT, Wagner EL, Choi JH, Li S, Reed R, et al. Necroptosis and apoptosis contribute to cisplatin and aminoglycoside ototoxicity. J Neurosci. (2019) 39:2951–64. doi: 10.1523/JNEUROSCI.1384-18.2019

PubMed Abstract | Crossref Full Text | Google Scholar

82. Prezant TR, Agapian JV, Bohlman MC, Bu X, Oztas S, Qiu WQ, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet. (1993) 4:289–94. doi: 10.1038/ng0793-289

PubMed Abstract | Crossref Full Text | Google Scholar

83. Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han D, et al. Maternally inherited aminoglycoside-induced and nonsyndromic deafness is associated with the novel C1494T mutation in the mitochondrial 12S rRNA gene in a large Chinese family. Am J Hum Genet. (2004) 74:139–52. doi: 10.1086/381133

PubMed Abstract | Crossref Full Text | Google Scholar

84. Hobbie SN, Akshay S, Kalapala SK, Bruell CM, Shcherbakov D, Böttger EC. Genetic analysis of interactions with eukaryotic rRNA identify the mitoribosome as target in aminoglycoside ototoxicity. Proc Natl Acad Sci USA. (2008) 105:20888–93. doi: 10.1073/pnas.0811258106

PubMed Abstract | Crossref Full Text | Google Scholar

85. Matt T, Ng CL, Lang K, Sha SH, Akbergenov R, Shcherbakov D, et al. Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin. Proc Natl Acad Sci USA. (2012) 109:10984–9. doi: 10.1073/pnas.1204073109

PubMed Abstract | Crossref Full Text | Google Scholar

86. Shulman E, Belakhov V, Wei G, Kendall A, Meyron-Holtz EG, Ben-Shachar D, et al. Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases. J Biol Chem. (2014) 289:2318–30. doi: 10.1074/jbc.M113.533588

PubMed Abstract | Crossref Full Text | Google Scholar

87. O'Reilly M, Young L, Kirkwood NK, Richardson GP, Kros CJ, Moore AL. Gentamicin affects the bioenergetics of isolated mitochondria and collapses the mitochondrial membrane potential in cochlear sensory hair cells. Front Cell Neurosci. (2019) 13:416. doi: 10.3389/fncel.2019.00416

PubMed Abstract | Crossref Full Text | Google Scholar

88. Schacht J. Biochemistry of neomycin ototoxicity. J Acoust Soc Am. (1976) 59:940–4. doi: 10.1121/1.380929

PubMed Abstract | Crossref Full Text | Google Scholar

89. Au S, Weiner ND, Schacht J. Aminoglycoside antibiotics preferentially increase permeability in phosphoinositide-containing membranes: a study with carboxyfluorescein in liposomes. Biochim Biophys Acta. (1987) 902:80–6. doi: 10.1016/0005-2736(87)90137-4

PubMed Abstract | Crossref Full Text | Google Scholar

90. Priuska EM, Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem Pharmacol. (1995) 50:1749–52. doi: 10.1016/0006-2952(95)02160-4

PubMed Abstract | Crossref Full Text | Google Scholar

91. Lesniak W, Pecoraro VL, Schacht J. Ternary complexes of gentamicin with iron and lipid catalyze formation of reactive oxygen species. Chem Res Toxicol. (2005) 18:357–64. doi: 10.1021/tx0496946

PubMed Abstract | Crossref Full Text | Google Scholar

92. Jiang H, Sha SH, Schacht J. Kanamycin alters cytoplasmic and nuclear phosphoinositide signaling in the organ of Corti in vivo. J Neurochem. (2006) 99:269–76. doi: 10.1111/j.1471-4159.2006.04117.x

PubMed Abstract | Crossref Full Text | Google Scholar

93. Kim J, Hemachandran S, Cheng AG, Ricci AJ. Identifying targets to prevent aminoglycoside ototoxicity. Mol Cell Neurosci. (2022) 120:103722. doi: 10.1016/j.mcn.2022.103722

PubMed Abstract | Crossref Full Text | Google Scholar

94. Hsieh CY, Tsai CY, Chou YF, Hsu CJ, Wu HP, Wu CC. Otoprotection against aminoglycoside- and cisplatin-induced ototoxicity focusing on the upstream drug uptake pathway. J Chin Med Assoc. (2024) 87:17–24. doi: 10.1097/JCMA.0000000000001023

PubMed Abstract | Crossref Full Text | Google Scholar

95. O'Reilly M, Kirkwood NK, Kenyon EJ, Huckvale R, Cantillon DM, Waddell SJ, et al. Design, synthesis, and biological evaluation of a new series of carvedilol derivatives that protect sensory hair cells from aminoglycoside-induced damage by blocking the mechanoelectrical transducer channel. J Med Chem. (2019) 62:5312–29. doi: 10.1021/acs.jmedchem.8b01325

PubMed Abstract | Crossref Full Text | Google Scholar

96. De la Torre P, Martínez- García C, Gratias P, Mun M, Santana P, Akyuz N, et al. Identification of druggable binding sites and small molecules as modulators of TMC1. bioRxiv. (2024) 2024:58361. doi: 10.1101/2024.03.05.583611

PubMed Abstract | Crossref Full Text | Google Scholar

97. Huth ME, Han KH, Sotoudeh K, Hsieh YJ, Effertz T, Vu AA, et al. Designer aminoglycosides prevent cochlear hair cell loss and hearing loss. J Clin Invest. (2015) 125:583–92. doi: 10.1172/JCI77424

PubMed Abstract | Crossref Full Text | Google Scholar